Jaroslaw Szczepaniak

13PUBLICATIONS
31CO-AUTHORS
NanomaterialsMolecular targetsEnvironmental epidemiologyEnvironmental biogeochemistryCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Aug 26, 2023
A Comprehensive Assessment of the Biocompatibility and Safety of Diamond Nanoparticles on Reconstructed Human Epidermis.

Wiktoria Fraczek, Kacper Kregielewski, Mateusz Wierzbicki

|Sep 09, 2022
Reduced Graphene Oxide Modulates the FAK-Dependent Signaling Pathway in Glioblastoma Multiforme Cells In Vitro.

Jaroslaw Szczepaniak, Malwina Sosnowska, Mateusz Wierzbicki

|Apr 23, 2022
Equid Alphaherpesvirus 1 Modulates Actin Cytoskeleton and Inhibits Migration of Glioblastoma Multiforme Cell Line A172.

Michalina Bartak, Marcin Chodkowski, Anna Słońska

|Aug 07, 2021
Comparison of the Toxicity of Pristine Graphene and Graphene Oxide, Using Four Biological Models.

Sławomir Jaworski, Barbara Strojny-Cieślak, Mateusz Wierzbicki

|Apr 30, 2021
The Effect of the Clenbuterol-β2-Adrenergic Receptor Agonist on the Peripheral Blood Mononuclear Cells Proliferation, Phenotype, Functions, and Reactive Oxygen Species Production in Race Horses In Vitro.

Olga Witkowska-Piłaszewicz, Rafał Pingwara, Jarosław Szczepaniak

|Jan 09, 2021
Reduced Graphene Oxides Modulate the Expression of Cell Receptors and Voltage-Dependent Ion Channel Genes of Glioblastoma Multiforme.

Jaroslaw Szczepaniak, Joanna Jagiello, Mateusz Wierzbicki

Pageof 3

Frequent Collaborators

9 joint publications

Marta Grodzik

8 joint publications

Mateusz Wierzbicki

7 joint publications

Barbara Strojny-Cieslak

5 joint publications

Andre Chwalibog